**For free weekly 8-12 page granular investment reports on individual small, attractive and underfollowed biotech stocks, just take five seconds to register @ biotechfreereports.com**
Market & Sector Snapshot
S&P ended the week up almost 1%, while IBB finished the week negative.
Current Watch List
Current lineup for potential analysis includes but is not limited to:
Syros Pharmaceuticals (NASDAQ:SYRS)
Ultragenyx Pharmaceuticals (NASDAQ:RARE)
Dividend Watch List
CSX Corporation (NYSE:CSX)
Lam Research Corporation (NASDAQ:LRCX)
Travelers Companies (NYSE:TRV)
In case you missed it, our Facebook group pick of the week was Imprimis Pharmaceuticals (IMMY), which is already up 10% after recommendation and could still see a 50% move or more this year.
As always my watchlist changes quite a bit, and some or all of above might not make the cut to articles. Any tickers you think should be added representing a near or mid term opportunity?